By Bobby Jindal & Charlie Katebi For decades, the United States has led the world in developing groundbreaking medications that allow patients to live longer and healthier lives. Despite these contributions, American families pay substantially higher prices for these breakthroughs than patients in any other country. The Trump administration just announced a major new policy […]

By Bobby Jindal & Charlie Katebi As healthcare costs continue to squeeze family budgets, Congress remains locked in debate over extending enhanced COVID-era Obamacare insurance company subsidies that artificially lower premiums for some consumers. Rather than wait for band-aid proposals from Congress, President Donald Trump is taking decisive action to deliver real reforms that lower […]

By Bobby Jindal and Hannah Anderson The government shutdown threatens to give dead people Medicaid benefits. Yes, you read that correctly. The radical and partisan proposal to reopen the government insists on repealing the provisions of the “Working Families Tax Cut” legislation to ensure that the dollars, doctors, and care are diverted to the people […]

By Bobby Jindal and Hannah Anderson President Donald Trump’s negotiations with pharmaceutical companies demonstrate how his Art of the Deal approach to governance produces results for working-class Americans. President Trump is the first national leader willing to drain the swamp, taking on powerful lobbyists and special interests to deliver lower prices for patients. Democrats have […]

By Bobby Jindal and Fran Soistman Business leaders and policymakers have been sounding the alarm for years: The employer-sponsored health insurance model is unsustainable. But with the cost of group health insurance premiums up 25% in five years, a fix may be in the works. Introduced during the first Trump administration, individual coverage Health Reimbursement […]